Immunology leaders decide what advances from discovery to clinic. The strongest executives link mechanism to evidence, focus portfolios, and keep programs moving efficiently. Klein Hersh connects you with those leaders.
Immunology drives modern drug development. From discovery through clinical translation, executives in this field guide target selection, indication strategy, and evidence generation that turns breakthrough science into patient impact. Demand for immunology executive talent is growing across pharma, biotech, and the healthcare marketplace, with a particular need in immuno-oncology, inflammation and autoimmunity, and neuroimmunology.
Where Immunology Leadership Matters Most
Immunology executives shape strategy and execution across the pipeline. These are the executives who:
- Build and shape research pipelines; define indication and biomarker strategy
- Lead translational plans that link mechanism to clinical endpoints
- Partner with translational medicine, clinical development
- Build external collaborations with academics, consortia, and CROs
- Guide portfolio decisions across therapeutic modalities (including small molecules, biologics, cell therapy, gene therapy, gene editing, siRNA, etc.)
These responsibilities demand leaders who prioritize indications, shape biomarker strategy, and de-risk pivotal trials .
Priority Areas in Immunology
We have access to the top talent that Pharma tech and services providers rely on to deliver the solutions and expertise that is the lifeblood of their business model.We focus on the immunology disciplines that shape verticals and clinical outcomes. These priority areas guide our approach to targeting and recruiting executive talent.
- Immuno‑oncology: Checkpoint inhibitors, T cell biology, myeloid targets, tumor microenvironment, adoptive cell therapies, combination strategies.
- Inflammation and autoimmunity: Cytokine signaling, tissue-resident immunity, fibrosis, precision patient segmentation, and flare prediction.
- Neuroimmunology: CNS immune pathways, neuroinflammation, microglia and astrocyte biology, and neurodegeneration interfaces
Why Organizations Trust Klein Hersh for Finding Top Immunology Executive Talent
With over 25 years in precision executive search, we deliver visionary leaders shaping the future of life sciences and healthcare. Our team is relationship-centered and industry-focused, with far-reaching networks across immunology in pharma, biotech, and platform companies. We tailor each search to your science, stage, and culture, and we move with speed and precision.
- Access to deep immunology talent across discovery, translational, and clinical leadership
- A process built on trust, clear communication, and rigorous evaluation
- Alignment to mission, culture, and scientific priorities
- Consistent delivery of leaders who accelerate innovation, enrich culture, and create lasting impact
The biggest benefits Klein Hersh provided was their speed to hire with qualified candidates. They are highly interactive and on-call as needed. Klein Hersh is simply the best.Immunology Recruiting with Impact
Progress in immunology depends on leaders who unite science and strategy. Klein Hersh connects companies with executives in immuno‑oncology, inflammation and autoimmunity, and neuroimmunology who strengthen pipelines, advance clinical programs, and improve patient outcomes.
Our work reflects the values that define Klein Hersh: precision search, industry immersion, and a commitment to delivering top talent that moves your organization forward.
